Objectives: To analyse Streptococcus agalactiae (group B Streptococcus; GBS) isolates collected in Poland from various human infections and carriage in respect of their clonality, distribution of virulence factors and antimicrobial resistance determinants, including the detection of transposons involved in the dissemination of antimicrobial resistance.
Introduction
Streptococcus agalactiae (group B Streptococcus; GBS), a commensal of human gastrointestinal and genitourinary flora, is now the major cause of early-onset sepsis in newborns, as well as an important factor of post-partum maternal sepsis and late-onset invasive infections in infants. GBS is also increasingly isolated from bacteraemia, endocarditis, skin and soft tissue infections, pneumonia and bone and joint infections in nonpregnant adults with underlying medical conditions. 1 This situation, together with an increasing resistance of GBS to macrolides observed worldwide, 2 -6 highlights the need for more detailed studies on its resistance determinants and population structure. Among typing methods applied to GBS, multilocus sequence typing (MLST) possesses a high discriminatory power combined with data portability. 7 Ten GBS serotypes (Ia, Ib and II -IX), specified by the polysaccharide capsule, are known 8 and five of these (Ia, Ib, II, III and V) are included in a vaccine that is in development. 9 Proteins of the a-like protein (Alp) family play an important role in GBS pathogenesis and are also vaccine candidates. 9 The Alp family includes the a, Rib, Alp2, Alp3/R28, Alp4 and 1 proteins, encoded by the allelic bca, rib, alp2, alp3, alp4 and alp1/alp5 genes, respectively, located on the pathogenicity island IV. 10, 11 Another virulence factor, the b-protein, encoded by the bac gene, together with a forms the so-called C-protein, the first known surface antigen of GBS. 11 The aim of this work was to characterize a collection of Polish GBS by antimicrobial susceptibility testing, investigation of antimicrobial resistance determinants and associated transposons, serotyping, MLST and analysis of alp gene distribution. To our knowledge, these are the first such data not only for Poland but also for the area of Central/Eastern Europe in general.
Materials and methods

Bacterial strains and patients' data
One hundred and fourteen GBS isolates were identified using standard criteria and sent to the National Medicines Institute (NMI), Poland, by 43 centres from 28 towns during the period 1996-2005. Meningitis isolates were obtained by the National Reference Centre for Bacterial Meningitis located at NMI, other invasive isolates and the majority of wound/skin isolates were collected by the National Network for Antimicrobial Resistance Monitoring at NMI, 12 most of the urine and carriage isolates were collected actively by NMI with the collaboration of 10 hospitals and the remaining isolates (22%), cultured from samples taken for routine diagnostics, were sent on a voluntary basis to NMI. The isolates were derived from wounds and skin lesions (39 
MLST, Alp protein genes and serotyping
MLST analysis was performed as originally proposed. 7 An online database (http://pubmlst.org/sagalactiae/) was used for assigning allele numbers and the sequence types (STs) were grouped with the eBURST program 13 into clonal complexes (CCs) whose members shared at least five of the seven MLST loci; 14 otherwise, an ST was considered a singleton. The diversity index was calculated as described previously. 15 The alp and bac genes were detected by PCR. 10, 16, 17 Serotyping of the isolates was performed by PCR-restriction fragment length polymorphism (PCR-RFLP) analysis of the cps locus. 18 
Antimicrobial resistance phenotypes and determinants
MICs of penicillin, erythromycin, tetracycline, clindamycin, telithromycin and co-trimoxazole (provided by their respective manufacturers) were evaluated as recommended by the CLSI using the CLSI-approved breakpoints, 19 with the exception of telithromycin and co-trimoxazole, for which the breakpoints proposed by the Comité de l'Antibiogramme de la Société Française de Microbiologie were applied. 20 Macrolide resistance phenotypes cMLS b , iMLS b and M were established by the double-disc test, 21 the erm(B), erm(A) and mef(A) resistance determinants were detected by PCR 22 and the structure of the erm(B) regulatory region was studied by sequencing. 23 The type of transposon associated with erm(B) was established using the proposed scheme 24 -26 with the following primer pairs: O6 and tetM2dg for the detection of Tn1545-like transposons; TETM2 and xis/rev for the detection of Tn3872-like transposons; and J11 and J12 for the detection of Tn6002-like, Tn6003-like and Tn2010-like transposons. For reactions where products .4 kb in size were expected, the Expand Template PCR system (Roche Diagnostics GmbH, Mannheim, Germany) was applied. The transposon-specific genes int and xis of Tn916, int of Tn5252, tnpA and tnpR of Tn917 and tndX of Tn5397 were detected by PCR. 27 -31 Primers and reaction conditions for the detection of tetracycline resistance genes tet(M), tet(O), tet(K), tet(L), tet(T) and tet(W) were as described by others; 27, 32, 33 the tet(M) polymorphism was further studied by PCR -RFLP with frequently cutting restriction enzymes AluI, HinfI, RsaI and SsiI, and sequencing of the representatives of variants observed in PCR-RFLP. The Lasergene (DNAStar Inc., Madison, WI, USA), ClonalFrame v1.1 34 and SplitsTree v4. 10 35 software packages were used for sequence alignments and analysis. The sequences of the tet(M) variants were submitted to GenBank under accession numbers GU3182218-GU318224.
Statistical analysis
The Fisher exact test was used to evaluate the differences in distributions of isolates. A P value of ≤0.05 was considered significant.
Results
MLST of GBS
Among 114 GBS isolates, 30 STs were observed (Table 1) . Nineteen STs, encompassing 103 isolates, were known previously and 11 were new (STs 272 -282), due to the presence of 12 novel alleles. One of these, adhP-57, contained the 5 nucleotide insertion 5
′ -GTCTT at nucleotide position 219 of the open reading frame (ORF), resulting in a truncated translation product. New STs were single locus variants of a main ST in a complex, resulting usually from a single nucleotide change; there was no novel allelic profile that contained a new combination of known alleles. All STs were grouped into four CCs and two singletons that contained 112 (98.2%) and two (1.8%) isolates, respectively. CC19 was significantly under-represented in invasive disease (P ¼ 0.03); no other statistically significant association between a CC and the form of infection was found. The diversity index for the group was 87.75% (95% CI, 83.64%-91.86%).
Serotypes and the alp family genes
Among the seven serotypes observed (Table 1) , serotype III was most prevalent (41 isolates, 36.0%), followed by Ia, V, Ib, II, IV and VI (20.2%, 17.5%, 13.2%, 10.5%, 1.8% and 0.9% of isolates, respectively). Serotype III, characteristic for all CC17 isolates and part of CC19 and CC23, accounted for 47.4% of invasive isolates (P ¼ 0.1), 64.3% of isolates from CSF (P ¼0.02) and 80.0% of LOD cases (P ¼ 0.005). Serotype Ia isolates of STs 23 and 24 were isolated from 38.5% of EOD cases (P ¼0.05). Serotype II, present in CC1, CC19 and ST22, was associated with a non-invasive disease and carriage (P ¼ 0.05). Genes encoding the Alp family of proteins (bca, rib, alp2, alp3 and alp1/alp5) were present in 17.5%, 26.3%, 16.7%, 14.9% and 23.7% of isolates, respectively ( Table 1) . The bac gene occurred in 17.5% of isolates, in association with bca or alp1/alp5, and was limited to CC1. The bca gene was also characteristic for all representatives of ST22 and ST24, which, however, lacked bac. The singleton ST26 was negative for all the alp genes tested.
Antimicrobial susceptibility of GBS isolates
All isolates were fully susceptible to penicillin and co-trimoxazole. Telithromycin exhibited good activity; two isolates were intermediately susceptible to this agent (MIC¼ 1.0 mg/L). The majority of isolates (104 isolates, 91.2%) were resistant to tetracycline. Twenty-one isolates (18.4%) were resistant to Sadowy et al. Table 1 . STs, serotypes, alp and bac genes, macrolide and tetracycline resistance determinants and transposons of Polish GBS isolates 
Macrolide and tetracycline resistance determinants
Isolates of the c MLS B , i MLS B and M phenotypes carried the erm(B), erm(A) and mef(A) genes, respectively ( Table 1) . Analysis of the erm(B) regulatory region, which includes the promoter, a short ORF encoding the 36 amino acid-long leader peptide (LP), and ribosome-binding sites for the LP and ErmB, revealed the presence of the original Tn917 sequence 30 in a single ST19 isolate and five additional variants among the remaining isolates. These changes included single-nucleotide substitutions, as well as a deletion within the LP ORF and a deletion between the 235 and 210 promoter sequences (Figure 1 The most common determinant of the ubiquitous tetracycline resistance was tet(M), found in 99 (95.2%) resistant isolates (Table 1) . Additionally, seven isolates, one isolate, two isolates and one isolate harboured tet(O), tet(L), tet(T) and tet(W), respectively; six isolates had more than one tet gene. The specificity of PCR for tet(L), tet(T) and tet(W) was verified by sequencing of the obtained product. Ten variants of tet(M) were detected by PCR-RFLP analysis; sequencing of the tet(M) ORF (1720 bp) of their representatives revealed mixed bases in two of them, found in three isolates, probably due to the presence of more than one tet(M) polymorph. Among the remaining eight variants, tet(M)-4 was reported previously in the 18854-s-1 strain of Enterococcus faecalis (GenBank accession number DQ223241). The divergence among tet(M) sequences reached 92.1% and 92.2% at the nucleotide and amino acid levels, respectively. Most numerous variants, such as tet(M)-2 (41 isolates) and tet(M)-3 (36 isolates), were characteristic for more than one CC, indicating their independent acquisition (Table 1) .
Transposons carrying the erm(B), mef(A) and tet(M) genes
In streptococci, macrolide and tetracycline resistances are frequently linked due to the localization of the erm(B) and tet(M) genes on the same composite transposons, Tn916 derivatives. The number of isolates is given in parentheses.
Sadowy et al.
Among the erm(B)-positive GBS isolates studied here, one isolate of ST255 was tetracycline susceptible, and lacked both tet(M) and int of Tn916, i.e. its erm(B) gene was not contained in a transposon of this family. This isolate was also negative for the transposase gene tnpA and resolvase gene tnpR of Tn917, as well as the resolvase gene tndX of Tn5397; the lack of tndX excluded transposon Tn1116, a derivative of Tn5397 with the inactivated tet(M) gene. 36 The remaining erm(B)-positive isolates concomitantly harboured the tet(M) gene. For these isolates, Tn2010-like transposons were assumed absent, as no isolate with both erm(B) and mef(A) was found. In the subsequent analysis, the primers O6 and tetM2dg yielded a 2.4 kb product, thus excluding the Tn1545-like transposon. All isolates gave a 0.8 kb product with primers J11 and J12, suggesting that none of them contained Tn6002-or Tn6003-like transposons. In 11 isolates of CC1, primers TETM2 and xis/rev yielded a 9.1 kb product, consistent with the presence of the Tn3872-like transposon ( Table 1 ). The linkage of erm(B) with such a transposon was confirmed by PCR with primers ermB1 and xis/rev. It is worth noting that these isolates differed in the regulatory region of erm(B). For the two remaining erm(B)-and tet(M)-positive isolates of ST19, a 3.8 kb product was observed with TETM2 and xis/rev primers, consistent with the presence of the Tn916-like transposon, carrying tet(M). One of these isolates harboured the tnpA and tnpR genes of Tn917; the tnpR gene was confirmed to be linked to erm(B) by PCR with primers ermB1 and tnpR-reverse. The other ST19 isolate was negative for tnpA, tnpR and tndX, i.e. it did not contain transposons Tn917 or Tn1116.
Three mef(A)-positive isolates also contained tet(M). For two of them, both of ST17, a 7 kb PCR product was observed with primers tetM-forward and mef-forward, indicating that both resistance genes were located on the Tn2009-like transposon; a single ST275 isolate was negative in this reaction. Both ST17 isolates, epidemiologically linked, contained concomitantly two variants of tet(M), which were carried by two elements (Tn2009-and Tn916-like transposons) independently.
The majority (63) of the tet(M)-positive isolates contained the integrase gene int of Tn916, with the exception of 36 isolates harbouring tet(M)-3. These isolates, however, yielded a PCR product with primers specific for the excisionase gene xis of the Tn916 transposon (verified by sequencing). The linkage of tet(M) with xis was further checked by PCR with primers specific for these two genes in the representatives of tet(M) variants that were positive, except for the tet(M)-3 isolates. The latter isolates yielded no product by PCR with primers J11 and J12 specific for Tn916, and were negative for the tndX gene of Tn5397. The presence of the tet(M)-1 variant, limited to CC1, coincided with the presence of the Tn3872-like transposon, identified during the analysis of erm(B)-carrying transposons, as described above. The location of tet(M)-1 on the Tn3872-like transposon in these isolates was confirmed by PCR with the primers tetM-forward and ermB2. The int gene of Tn5252 was absent from all the tet(M)-positive isolates, indicating that Tn916 was not a part of the composite Tn5253 transposon. Therefore, in the majority of isolates, various variants of tet(M) were located on Tn916-like transposons or their derivatives, such as Tn3872-and Tn2009-like transposons. One variant of tet(M) was not associated with a known type of transposon.
Discussion
One of the properties specific for GBS seems to be a remarkably clonal population structure, with strong differences in the degree of divergence within particular clonal groups. In this study, 114 isolates belonged to 30 STs (3.8 isolates/ST), while in a global collection of GBS, 30 STs occurred among 152 isolates (5.1 isolates/ ST) 7 and in Israel 46 STs characterized 154 isolates (3.5 isolates/ ST). 14 In each of these studies, the STs belonged to relatively few CCs, which encompassed the majority of isolates, and the same STs predominated, such as 1, 17, 19 and 23. The degree of variability of pathogenic factors, such as serotype and surface protein genes, differed for particular CCs. While the homogeneous CC17 was characterized by serotype III and showed the uniform presence of the rib gene, CC1 and CC23 were much more internally variable. 7, 14, 37 These differences among CCs may be due to different capabilities for horizontal gene transfer, whose mechanism remains unclear in GBS.
Some studies pointed to a diverse ability of particular clones to cause invasive disease and, in particular, hypervirulent properties have been postulated for CC17. 7, 14 In our study, 50% of the isolates belonging to this CC were obtained from patients with an invasive disease, while such isolates constituted one-third of the entire group; yet this tendency did not reach statistical significance. On the other hand, isolates of ST1 and ST19 were over-represented among carriage isolates in the global GBS strain collection; 7 this tendency was also observed here for CC19, whose representatives were significantly associated with non-invasive infections and carriage. 
Group B streptococci in Poland
Five of the GBS serotypes (Ia, Ib, II, III and V) are most frequently involved in neonatal invasive disease, adult infections and maternal carriage, with the prevalence of the predominant serotype III varying between 29% and 54%, 14,38 -40 depending on the country and the source of isolation. In our study, isolates of serotype III accounted for 36% of all isolates. Some studies have suggested increased invasiveness of this serotype 41, 42 and its association with meningitis. 40 In our study, serotype III isolates were more prevalent among invasive infections in general, and particularly among meningeal isolates and isolates from LOD cases, in agreement with the fact that serotype III was characteristic for isolates of CC17, responsible for a high proportion of late-onset meningitis. 43 EOD cases were found to be associated with isolates of serotype Ia and ST23/24, as seen by others. 42 Serotype II, in our study, showed a tendency to be associated with non-invasive infections and carriage, similar to in other studies. 14 The coverage of the developed vaccine 9 would be 97.4%, both in general and for invasive disease. For a long time, GBS remained fully susceptible to penicillin, 2,4 -6 the first-line drug used in the treatment and prophylaxis of infections caused by this pathogen. The current alternatives for patients allergic to penicillin include macrolides and lincosamides. In the USA, 24.5% and 41.9% of invasive and colonizing isolates, respectively, were erythromycin resistant. 2 In Europe, erythromycin resistance amounted to 10% -16.5% in Portugal, Germany, Spain and Italy. 4 -6,44 The resistance level observed in Poland, i.e. 18.4%, indicates the need for careful surveillance in the future, especially as the first penicillin-non-susceptible GBS were reported in the USA and Japan; 45, 46 this dangerous phenomenon may lead to further limitation of treatment options.
Resistance to erythromycin in streptococci is mediated by two major mechanisms: methylation of the 23S ribosomal RNA, determined by erm genes, expressed constitutively or inducibly (MLS B phenotype); and active drug efflux by pumps encoded by mef genes (M phenotype). Among Polish GBS, the cMLS B phenotype, associated with the erm(B) determinant, was the most prevalent, which is in agreement with the findings from other European countries. 4,44,47 -49 In our study, the majority of resistant isolates belonged to ST1 and serotype V, and such association was also found in other countries. 2, 4, 44 The changes within the regulatory region of the erm(B) gene that led to non-susceptibility to a new ketolide, telithromycin, are of particular concern. Changes in the regulatory region of erm(B) in Streptococcus pneumoniae, resulting in different forms of truncated LP, led to telithromycin non-susceptibility in this pathogen. 50 The resistance to tetracycline, which appears a very common feature of GBS, is typically mediated by the tet(M) gene in this species. 51 We observed a significant variability of tet(M) among Polish GBS and the analysis of the distribution of these variants among CCs showed that they probably were acquired in several independent events. Diversity of tet(M) and the mosaic structure of this gene were described in several species of Grampositive bacteria. 27,31,51 -53 The presence of a parallelogram in the consensus network of tet(M) suggests a recombination event in the evolution of tet(M) genes analysed in the current study. It was proposed that the presence of two alleles of tet(M) in the same bacterial cell in the case of enterococci provided an opportunity for the recombination of these genes 31 and our study showed that some GBS strains indeed harboured two copies of tet(M), due to the acquisition of two mobile elements carrying this gene.
So far, only limited information is available on the epidemiology of genetic mobile elements associated with antimicrobial resistance determinants in GBS. In the current study, in the majority of isolates the erm(B) gene was carried on the Tn3872-like transposon. Such an element was recently described in a GBS strain 54 and for a collection of macrolide-resistant Streptococcus pyogenes.
36
The most extensively studied streptococcal species, S. pneumoniae, varied in transposon type distribution among countries. 26 The role of Tn916 transposons in the dissemination of tetracycline resistance is currently well established. 55 Although for the majority of isolates carrying resistance determinants to tetracycline and macrolides, the type of transposon involved in their dissemination was successfully identified, for some isolates putative mobile elements remained unknown, such as in the case of two isolates with erm(B), one isolate with mef(A) and the group of isolates with tet(M)-3. It cannot be ruled out that these determinants were carried on plasmids. There are several examples of erm and tet genes on small, mobilizable, broad-host-range plasmids in Gram-positive bacteria 51,52,56 -58 that potentially might be acquired by and replicate in GBS. Another possibility would be a novel transposon or a rearrangement of a known transposon. Interestingly, an isolate that was positive for the xis and tet(M) genes, but negative for int, i.e. similar to GBS isolates with tet(M)-3, was described in S. pneumoniae; 28 for this species no plasmids containing antimicrobial resistance genes are known. The very high level of the dissemination of tetracycline resistance in Polish GBS, driven by mobile genetic elements, such as the Tn916 transposon family, indicates the threat of a similar scenario for macrolides and ketolides in the future.
In summary, Polish GBS represent a complex population, formed by several events of recombination, gene acquisition and, presumably, their further evolution. The knowledge of serotype distribution, capsule switching and exchange of the alp genes will be of particular importance for vaccine development, based on conjugated capsular polysaccharides and surface proteins. The data presented here will contribute to a better understanding of the spread of macrolide and tetracycline resistance among GBS, which may also represent an important reservoir of resistance genes for other species.
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